You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Cilostazol in NICE guideline

https://doi.org/10.1136/heartjnl-2012-302092

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Linked article 302093.

    • Competing interests SBM: Servico de Angiologia, Cirugia Vascular y Endovascular, Hospital de la Santa Creu i Sant Pau, Barcelona. PNRA: Medical Department, Ferrer Internacional, S.A. Grupo Ferrer. JRER: Servicio de Angiologia, Cirugia Vascular y Endovascular, Hospital de la Santa Creu i Sant Pau, Barcelona. SBM declares receiving lecture fees from Ferrer Internacional, S.A. PNRA declares he is a full-time employee of Ferrer Internacional, S.A., which distributes cilostazol in Spain. JRER declares receiving consulting and lecture fees from Ferrer Internacional, S.A.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • PostScript
      The Authors' reply
      Joseph Shalhoub Alun H Davies
      Heart 2012; 98 1107-1108 Published Online First: 27 Jun 2012. doi: 10.1136/heartjnl-2012-302093